| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
microRNA 6785 | 0.931 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 2605 | 0.490 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||
|
H3 histone pseudogene 13 | 0.584 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | |||||||||
|
H3 histone pseudogene 23 | 0.443 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
ZFP42 zinc finger protein | 0.678 | 0.346 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
major histocompatibility complex, class II, DR beta 3 | 0.570 | 0.885 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1992 | 1992 | |||||||||
|
major histocompatibility complex, class II, DR beta 4 | 0.565 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
microRNA 10a | 0.513 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
microRNA 126 | 0.447 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
microRNA 221 | 0.449 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
microRNA 29b-1 | 0.485 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
microRNA 29b-2 | 0.484 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
microRNA 34a | 0.421 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
microRNA 148b | 0.592 | 0.692 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
mannose-binding lectin family member 3, pseudogene | 0.518 | 0.769 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | |||||||||
|
WT1 antisense RNA | 0.597 | 0.615 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
microRNA 421 | 0.592 | 0.692 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 642a | 0.769 | 0.308 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | |||||||||
|
teratocarcinoma-derived growth factor 1 pseudogene 3 | 0.631 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | |||||||||
|
centriolin | 0.711 | 0.423 | 1.9E-54 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 |